Multimodality noninvasive imaging in the evaluation of coronary artery disease: a narrative review
Abstract
Coronary artery disease (CAD) remains a leading cause of cardiovascular morbidity and mortality, and its evaluation has evolved beyond the identification of obstructive epicardial stenosis alone. Contemporary imaging increasingly emphasizes an integrated assessment of coronary anatomy, plaque burden and composition, lesion-specific ischemia, myocardial viability, scar, ventricular remodeling, and coronary microvascular dysfunction. Anatomic and functional imaging provide complementary information regarding coronary atherosclerosis, lesion-specific physiology, inducible ischemia, myocardial blood flow, viability, scar, and microvascular disease, with test selection guided by the clinical question and patient characteristics. Randomized trials of specific imaging-guided strategies have demonstrated differences in diagnostic efficiency, downstream invasive angiography, preventive therapy, revascularization, and procedural complications. In contrast, effects on symptoms and hard cardiovascular outcomes vary according to the population, comparator, and duration of follow-up. Emerging technologies, including artificial intelligence, radiomics, photon-counting computed tomography, molecular imaging, and hybrid imaging, are at different stages of clinical readiness and require varying degrees of further validation before routine implementation. This review summarizes the current role, evidence base, limitations, and future directions of multimodality noninvasive imaging in CAD, providing a practical framework for selecting the appropriate test according to the clinical question and patient profile.